In 2023, pancreatic cancer transitioned from being a rare form to a common cancer in Australia—a troublesome statistic, seeing as it has very low survival rates of about 12%. The symptoms of pancreatic cancer are in advanced stages, making it difficult to treat.
Read More
Clinical state oncology company Prescient Therapeutics (ASX: PTX) has received the US FDA’s Orphan Drug Designation for its PTX-100 drug, used for cancer treatment. Previously, the Company received ODD for peripheral T-cell lymphomas (PTCL) in 2022. Following that, it applied for ODD for cutaneous T-cell lymphomas (CTCL), and it was granted a blanket designation for
Read More
Offering some relief for people suffering from prostate cancer, Starpharma (ASX: SPL) might be on the verge of a breakthrough as it announced that its drug DEP® cabazitaxel has shown promising anti-tumour activity data at the European Society of Medical Oncology (ESMO) Congress in Paris, France. The new data from its phase 2 trial reveals
Read More
Since securing a European patent for their proprietary cancer vaccine HER-Vaxx, Imugene (ASX: IMU) have been busy. The Company has now announced the initiation of new clinical trials in collaboration with global pharmaceutical company, Merck & Co (NYSE: MRK). The USD $46 billion company will support Imugene in evaluating the efficacy and safety of HER-Vaxx
Read More
Sunbaking is a certified Australian pastime, so it comes as no surprise that we have the highest melanoma rate in the world. Any lamington-eating, Waltzing Matilda-singing Aussie knows that skin checks are an important part of preventative healthcare, and that our unfortunate position in relation to the inconvenient hole in our ozone layer means that
Read More
Cancer treatment is slowly shifting away from the standard chemo and radiation and more towards immunotherapy as an alternative treatment. Unlike chemotherapy which destroys healthy, rapidly dividing cells in the body, immunotherapy is more targeted, using the patient’s own immune system to fight cancer. Chemotherapy’s attack on healthy cells causes the well known side effects
Read More